ASB-2 inhibits growth and promotes commitment in myeloid leukemia cells.
about
ASB proteins interact with Cullin5 and Rbx2 to form E3 ubiquitin ligase complexesAnkyrin repeat and suppressors of cytokine signaling box protein asb-9 targets creatine kinase B for degradationThe role of cullin 5-containing ubiquitin ligasesThe E3 ubiquitin ligase specificity subunit ASB2beta is a novel regulator of muscle differentiation that targets filamin B to proteasomal degradationMacrophage mesenchymal migration requires podosome stabilization by filamin AFilamins in mechanosensing and signaling.Characterisation of genome-wide PLZF/RARA target genes.ASB2 is an Elongin BC-interacting protein that can assemble with Cullin 5 and Rbx1 to reconstitute an E3 ubiquitin ligase complex.Filamins but not Janus kinases are substrates of the ASB2α cullin-ring E3 ubiquitin ligase in hematopoietic cells.The E3 ubiquitin ligase specificity subunit ASB2α targets filamins for proteasomal degradation by interacting with the filamin actin-binding domainFunctional and structural insights into ASB2alpha, a novel regulator of integrin-dependent adhesion of hematopoietic cellsECSASB2 mediates MLL degradation during hematopoietic differentiationThe Role of Elongin BC-Containing Ubiquitin Ligases.Substrates of the ASB2α E3 ubiquitin ligase in dendritic cells.Global identification of MLL2-targeted loci reveals MLL2's role in diverse signaling pathwaysIdentification of an epigenetic profile classifier that is associated with survival in head and neck cancer.Integrated expression analysis of muscle hypertrophy identifies Asb2 as a negative regulator of muscle mass.ASB2 targets filamins A and B to proteasomal degradation.ASB2α, an E3 ubiquitin ligase specificity subunit, regulates cell spreading and triggers proteasomal degradation of filamins by targeting the filamin calponin homology 1 domainPromoter analysis and tissue expression of the chicken ASB15 gene.A label-free quantitative proteomics strategy to identify E3 ubiquitin ligase substrates targeted to proteasome degradation.Ankyrin repeat and SOCS box protein 15 regulates protein synthesis in skeletal muscle.Notch-induced Asb2 expression promotes protein ubiquitination by forming non-canonical E3 ligase complexes.Altered mRNA abundance of ASB15 and four other genes in skeletal muscle following administration of beta-adrenergic receptor agonists.Role of N6-methyladenosine modification in cancer.N6-methyladenosine links RNA metabolism to cancer progression.FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase.Polymorphisms of Flanking Region of the ASB15 Gene and Their Associations with Performance Traits in Chicken.RNA N6-methyladenosine modification in cancers: current status and perspectives.Multiple functions of m6A RNA methylation in cancer.N6-methyladenine RNA modification and cancers
P2860
Q24297841-632E3868-3680-453E-9A9C-F0129725012CQ24322983-20954A3F-2FF5-4E15-B7A1-F05C527E3D65Q26749274-B8DEC2A3-AC9B-465D-9619-442341D7F3FEQ28512761-628ACF34-9890-49F8-A686-5E184884C489Q30513877-58E40F89-C426-4719-9AA5-DF409DD5619EQ33900830-11968DA3-9A47-47D1-889D-9518F8DB2285Q34031285-9EF2A794-62D5-48DA-8D66-95217BD2C8C2Q34375157-BB299E0F-3D24-42D3-84CC-138B4072BE7DQ34391842-B2D2AECB-47A9-41FD-96D8-670A454DC042Q35112298-9B7ED756-9B9F-4F76-8BAE-B5A202D9E06CQ35182907-25F6BFD8-9160-4018-817B-4E33466D9EB5Q35750333-1EDD7812-412A-42A5-969F-CD4ADBE33455Q35971082-089F4279-14FF-45EC-9543-12A724223789Q36249918-7A8E33C3-1B7C-42F0-8CC7-0870461560CFQ36378382-53B4D0D4-8535-48FE-A5E4-B37FB6005C22Q36833387-DA9379A5-58BB-4E9A-B8FA-F2BF2D2F44C4Q36890245-3319A4FE-9B0C-499E-A54F-8BCBBC7C84BBQ37003539-83D85A6D-8368-48AF-A6B2-FB6D18853A2DQ37272236-AAC50E3D-B2A4-471F-BA4A-5D4151D5ABE5Q39187390-F5E93A48-D315-48CA-AE89-33964CB07EDAQ39859325-196F5317-407D-48F6-A720-8AEE8DA20C99Q40327490-10B35408-C7CF-4FDD-853F-7413E498DCD5Q42725282-DB8E20CF-5A75-494C-B9BA-6400CC7F5462Q44674293-A1CF1A6B-1A23-4820-AF34-E0BA7DA7AB13Q47567064-5AACE105-90BB-429A-A849-EE9F2D5B5783Q49646778-06AFD099-59F1-4E27-AE3D-D1B68C8FBEC1Q51236778-EDB95BE9-0DF3-4A62-8D18-E1342B136BB6Q51398530-7C28EEBC-3268-45D6-A42C-D4CF37C29ABFQ52311777-3A24FBED-6955-4328-99E4-D6B4CFF61E25Q52627227-B4C421E6-3C4B-4BBF-BC69-F66990F9374CQ58790037-3DF56245-C864-4253-891E-6929ADA95C7B
P2860
ASB-2 inhibits growth and promotes commitment in myeloid leukemia cells.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
ASB-2 inhibits growth and promotes commitment in myeloid leukemia cells.
@ast
ASB-2 inhibits growth and promotes commitment in myeloid leukemia cells.
@en
ASB-2 inhibits growth and promotes commitment in myeloid leukemia cells.
@nl
type
label
ASB-2 inhibits growth and promotes commitment in myeloid leukemia cells.
@ast
ASB-2 inhibits growth and promotes commitment in myeloid leukemia cells.
@en
ASB-2 inhibits growth and promotes commitment in myeloid leukemia cells.
@nl
prefLabel
ASB-2 inhibits growth and promotes commitment in myeloid leukemia cells.
@ast
ASB-2 inhibits growth and promotes commitment in myeloid leukemia cells.
@en
ASB-2 inhibits growth and promotes commitment in myeloid leukemia cells.
@nl
P2093
P2860
P356
P1476
ASB-2 inhibits growth and promotes commitment in myeloid leukemia cells.
@en
P2093
Christel Moog-Lutz
Florence C Guibal
Piotr Smolewski
Yolande Di Gioia
Yvon E Cayre
P2860
P304
P356
10.1074/JBC.M108476200
P407
P577
2001-10-26T00:00:00Z